Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Annals of Thoracic Surgery|October 28, 2017
Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?Neel P Chudgar, Murray F Brennan, Kay See Tan, et al.
Ecancermedicalscience|October 21, 2020
SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic reviewGuilherme Haradaa, Fernanda F Antonacio, Aline Bl Gongora, et al.
The Oncologist|June 12, 2016
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First MetastasisDeborah Kuk, Alexander N Shoushtari, Christopher A Barker, et al.
The Oncologist|May 10, 2015
A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain MetastasesJames J Harding, Federica Catalanotti, Rodrigo R Munhoz, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 12, 2017
Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcomaNeel P Chudgar, Murray F Brennan, Rodrigo R Munhoz, et al.
JCO Global Oncology|July 18, 2024
Discordance Between the Initial Diagnosis of Sarcomas and Subsequent Histopathological Revision and Molecular Analyses in a Sarcoma Reference Center in BrazilCarlos Diego H Lopes, Marcello M Queiroz, Luana A F Sampaio, et al.
Cancer|August 18, 2016
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodiesAlain P Algazi, Katy K Tsai, Alexander N Shoushtari, et al.
Melanoma Research|October 30, 2016
Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanomaAlexander N Shoushtari, Mark J Bluth, Debra A Goldman, et al.
Cancer|October 24, 2022
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinomaRodrigo R Munhoz, Guilherme Nader-Marta, Veridiana P de Camargo, et al.
Ecancermedicalscience|May 22, 2024
Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023Heloisa Resende, Roberto J Arai, Carlos H Barrios, et al.
Pageof 3